Sponsor Pipeline

EHL Bio Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07377838 Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic… Atopic Dermatitis Not Yet Recruiting
Phase 2
NCT04137562 Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic… Atopic Dermatitis Active, Not Recruiting
Disease Areas
Atopic Dermatitis (2)
Get alerts when EHL Bio Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free